Pricing Log in Create free account
Saturday 17 October 2026 Export MCK’s income statement to Excel — free account

McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.

1,006.92 8.28 +0.83%
Market cap
$116.4B
P/E
26.8×
Fwd P/E
18.3×
Dividend yield
0.34%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

McKesson Corporation (MCK) EPS (diluted)

Alert me on EPS (diluted)

McKesson Corporation's EPS (diluted) for fiscal 2026 was $38.38, up 49.2% from $25.72 in fiscal 2025. Over the twelve months to 30 June 2026 it was $37.37. Over the past ten years it has ranged from −$28.26 (fiscal 2021) to $38.38 (fiscal 2026) — the current reading is the highest in ten years. McKesson Corporation ranks 1st of 10 Medical Distribution companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2026 $38.38 49.22%
FY2025 $25.72 14.87%
FY2024 $22.39 (10.55%)
FY2023 $25.03 246.20%
FY2022 $7.23 —
FY2021 −$28.26 —
FY2020 $4.95 2,811.76%
FY2019 $0.17 (46.87%)
FY2018 $0.32 (98.59%)
FY2017 $22.73 134.33%

Quarterly newest first

Period EPS (diluted) Change
Jun 2026 $5.15 (62.44%)
Mar 2026 $13.71 42.96%
Dec 2025 $9.59 7.51%
Sep 2025 $8.92 42.72%
42 more quarters

Against its own ten years

Low −$28.26 High $38.38
Ten-year median $8.47
Current reading's percentile 100

EPS (diluted) against peers

Company EPS (diluted)
MCK McKesson Corporation $37.37
COR Cencora, Inc. compare $13.46
CAH Cardinal Health, Inc. compare $7.23
HSIC Henry Schein, Inc. compare $3.43
AHG Akso Health Group Sponsored ADR compare −$0.55
COSM Cosmos Health Inc. compare −$0.64
FOCL FocalTherics compare −$1.03
ACH Accendra Health, Inc. compare −$3.91
HKPD Cellyan Biotechnology Co., Ltd compare —

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on MCK